- The Economic Burden of Epilepsy in Korea, 2010
-
Jaehun Jung, Hye-Young Seo, Young Ae Kim, In-Hwan Oh, Yo Han Lee, Seok-Jun Yoon
-
J Prev Med Public Health. 2013;46(6):293-299. Published online November 28, 2013
-
DOI: https://doi.org/10.3961/jpmph.2013.46.6.293
-
-
9,707
View
-
126
Download
-
10
Crossref
-
 Abstract
 PDF
- Objectives
The purposes of this study were to evaluate the prevalence of epilepsy and to estimate the cost of epilepsy in Korea, 2010. MethodsThis study used a prevalence based approach to calculate the cost of epilepsy. Claims data from the Korean national health insurance and data from the Korea health panel, the Korea National Statistical Office's records of causes of death, and labor statistics were used to estimate the cost of epilepsy. Patients were defined as those who were hospitalized or visited an outpatient clinic during 2010 with a diagnosis of epilepsy (International Classification of Diseases 10th revision codes G40-G41). Total costs of epilepsy included direct medical costs, direct non-medical cost and indirect costs. ResultsThe annual prevalence of treated epilepsy was 228 per 100 000 population, and higher in men. The age-specific prevalence was highest for teenagers. The total economic burden of epilepsy was 536 billion Korean won (KW). Indirect cost (304 billion KW) was 1.3 times greater than direct cost (232 billion KW). By gender, the male (347 billion KW) were more burdened than the female (189 billion KW). The estimated cost in young age younger than 20 years old was 24.5% of the total burden of epilepsy. ConclusionsA significant portion of the economic burden of epilepsy is borne by people in young age. To reduce the economic burden of epilepsy, effective prevention and treatment strategies are needed.
-
Summary
-
Citations
Citations to this article as recorded by  - Evaluation of persistence and healthcare utilization in patients treated with anti-seizure medications as add-on therapy: A nationwide cohort study in South Korea
Ji Woong Lee, Jung-Ae Kim, Min Young Kim, Sang Kun Lee
Epilepsy & Behavior.2022; 126: 108459. CrossRef - Cost of Illness of Epilepsy and Associated Factors in Patients Attending Adult Outpatient Department of University of Gondar Referral Hospital, Northwest Ethiopia
Piniel Melkamu, Yaregal Animut, Amare Minyihun, Asmamaw Atnafu, Mezgebu Yitayal
Risk Management and Healthcare Policy.2021; Volume 14: 2385. CrossRef - Cost–benefit analysis, cost-effectiveness analysis, and impact of antiepileptic drugs on the risk of fracture in patients with epilepsy: A nationwide cohort study
Hsin-Hsuan Cheng, Pei-Tseng Kung, Bo-Ren Wang, Li-Ting Chiu, Wen-Chen Tsai
Epilepsy & Behavior.2020; 103: 106851. CrossRef - Introducing big data analysis using data from National Health Insurance Service
EunJin Ahn
Korean Journal of Anesthesiology.2020; 73(3): 205. CrossRef - Epilepsy in Asia: Disease burden, management barriers, and challenges
Eugen Trinka, Patrick Kwan, ByungIn Lee, Amitabh Dash
Epilepsia.2019; 60(S1): 7. CrossRef - The Present and Future of Vagus Nerve Stimulation
Jeyul Yang, Ji Hoon Phi
Journal of Korean Neurosurgical Society.2019; 62(3): 344. CrossRef - Costs of informal nursing care for patients with neurologic disorders
Freya Diederich, Hans-Helmut König, Claudia Mietzner, Christian Brettschneider
Neurology.2018; 90(1): 28. CrossRef - The Economic Burden of Hepatitis A, B, and C in South Korea
Changwoo Shon, Hyung-Yun Choi, Jae-Jun Shim, So-Youn Park, Kyung Suk Lee, Seok-Jun Yoon, In-Hwan Oh
Japanese Journal of Infectious Diseases.2016; 69(1): 18. CrossRef - A nationwide epidemiological study of newly diagnosed spine metastasis in the adult Korean population
Seil Sohn, Jinhee Kim, Chun Kee Chung, Na Rae Lee, Eunjung Park, Ung-Kyu Chang, Moon Jun Sohn, Sung Hwan Kim
The Spine Journal.2016; 16(8): 937. CrossRef - The direct costs of epilepsy in Russia. A prospective cost-of-illness study from a single center in Moscow
Alla Guekht, Maria Mizinova, Igor Kaimovsky, Oksana Danilenko, Elisa Bianchi, Ettore Beghi
Epilepsy & Behavior.2016; 64: 122. CrossRef
|
KSPM
